Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Two-phase, Multi-dose, Prospective, Randomized, Double-blind, Placebo-Controlled Study of Safety and Efficacy of Microporous, Fractionated, Protonated Zirconium Silicate in Mild to Moderate Hyperkalemia

NCT01737697 is registered in ClinicalTrials.gov with ZS Pharma, Inc. as lead sponsor.

NCT NCT01737697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01737697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Two-phase, Multi-dose, Prospective, Randomized, Double-blind, Placebo-Controlled Study of Safety and Efficacy of Microporous, Fractionated, Protonated Zirconium Silicate in Mild to Moderate Hyperkalemia
Lead sponsor
ZS Pharma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2012
Completion date
November 30, 2013
Enrollment
754 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia